Skip to main content

Advertisement

SpringerLink
Log in

Candida Infectious Endocarditis and Implantable Cardiac Device Infections

  • Review
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Intravascular diseases due to Candida species, including endocarditis and cardiac device-associated infections, are rare yet devastating manifestations of invasive candidiasis affecting an already vulnerable population. Despite their significant associated morbidity and mortality, limited prospective data exist to inform the optimal diagnostic and therapeutic approaches to these entities. Herein, we review the existing literature pertaining to the epidemiology, diagnosis, and management of infectious endocarditis, rhythm management device infections, and circulatory support device infections caused by Candida species and suggest areas for future research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benedict K, Whitham HK, Jackson BR. Economic burden of fungal diseases in the United States. Open Forum Infect Dis. 2022;9:6–9.

    Article  Google Scholar 

  2. Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25:1200–12. https://doi.org/10.1016/j.cmi.2019.04.024.

    Article  CAS  PubMed  Google Scholar 

  3. Rayens E, Norris KA. Prevalence and healthcare burden of fungal infections in the United States, 2018. In: Open forum infectious. Oxford: Oxford University Press; 2022, p. 9

  4. Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445–56. https://doi.org/10.1056/NEJMra1315399.

    Article  CAS  PubMed  Google Scholar 

  5. Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73:i4–13.

    Article  CAS  PubMed  Google Scholar 

  6. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17:255–67.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ. The role of echinocandins in Candida biofilm-related vascular catheter infections: in vitro and in vivo model systems. Clin Infect Dis. 2015;61:S618–21.

    Article  CAS  PubMed  Google Scholar 

  8. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, López-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother. 2002;46:3634–6. https://doi.org/10.1128/AAC.46.11.3634-3636.2002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Badiee P, Amirghofran AA, Nour MG, Shafa M, Nemati MH. Incidence and outcome of documented fungal endocarditis. Int Cardiovasc Res J. 2014;8:152.

    PubMed  PubMed Central  Google Scholar 

  11. Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miró JM, et al. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother. 2015;59:2365–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Baddley JW, Benjamin DK, Patel M, Miró J, Athan E, Barsic B, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519–29. https://doi.org/10.1007/s10096-008-0466-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, et al. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18:E99-109. https://doi.org/10.1111/j.1469-0691.2012.03764.x.

    Article  CAS  PubMed  Google Scholar 

  14. Foong KS, Sung A, Burnham JP, Kronen R, Lian Q, Salazar Zetina A, et al. Risk factors predicting Candida infective endocarditis in patients with candidemia. Med Mycol. 2019;58:593–9.

    Article  PubMed Central  Google Scholar 

  15. Fernández-Cruz A, Cruz Menárguez M, Muñoz P, Pedromingo M, Peláez T, Solís J, et al. The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? a prospective cohort. Eur J Clin Microbiol Infect Dis. 2015;34:1543–9.

    Article  PubMed  Google Scholar 

  16. Hitzenbichler F, Joha T, Simon M, Grosse J, Menhart K, Hellwig D, et al. Candida endocarditis in patients with candidemia: a single-center experience of 14 cases. Mycopathologia. 2020;185:1057–67. https://doi.org/10.1007/s11046-020-00492-3.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Huggins JP, Hohmann S, David MZ. Candida infective endocarditis: a retrospective study of patient characteristics and risk factors for death in 703 United States cases, 2015–2019. Open Forum Infectious Diseases. Oxford: Oxford Academic; 2021. p. 8. https://academic.oup.com/ofid/article/8/2/ofaa628/6041656 Accessed from 27 Oct 2022.

  18. Guo P, He Y, Fan R, Wu Z, Chen Y, Huang Y, et al. A case series of medically managed Candida parapsilosis complex prosthetic valve endocarditis. Ann Clin Microbiol Antimicrob. 2021;20:1–10. https://doi.org/10.1186/s12941-020-00409-4.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.

    Article  CAS  PubMed  Google Scholar 

  20. Sun XL, Zhang J, Wang GG, Zhuang XF, Yang YM, Zhu J, et al. Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. Am J Cardiol. 2013;112:111–6.

    Article  PubMed  Google Scholar 

  21. Nasser RM, Melgar GR, Longworth DL, Gordon SM. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med. 1997;103:25–32.

    Article  CAS  PubMed  Google Scholar 

  22. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Dental and cardiac risk factors for infective endocarditis: a population-based, case-control study. Ann Intern Med. 1998;129:761–9.

    Article  CAS  PubMed  Google Scholar 

  23. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the american heart association. Circulation. 2007;116:1736–54.

    Article  PubMed  Google Scholar 

  24. El-Dalati S, Cronin D, Shea M, Weinberg R, Riddell J, Washer L, et al. Clinical practice update on infectious endocarditis. Am J Med. 2020;133:44–9.

    Article  CAS  PubMed  Google Scholar 

  25. Gould FK, Denning DW, Elliott TSJ, Foweraker J, Perry JD, Prendergast BD, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of the british society for antimicrobial chemotherapy. J Antimicrob Chemother. 2012;67:269–89.

    Article  CAS  PubMed  Google Scholar 

  26. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation. 2015;132(15):1435–86.

    Article  CAS  PubMed  Google Scholar 

  27. Venditti M, Falcone M, Micozzi A, Carfagna P, Taglietti F, Serra PF, et al. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica. 2003;88:923–30.

    PubMed  Google Scholar 

  28. Seelig MS, Speth CP, Kozinn PJ, Taschdjian CL, Toni EF, Goldberg P. Patterns of Candida endocarditis following cardiac surgery: Importance of early diagnosis and therapy (an analysis of 91 cases). Prog Cardiovasc Dis. 1974;17:125–60.

    Article  CAS  PubMed  Google Scholar 

  29. Rivoisy C, Vena A, Schaeffer L, Charlier C, Fontanet A, Delahaye F, et al. Prosthetic valve Candida spp. Endocarditis: new insights into long-term prognosis-the ESCAPE study. Clin Infect Dis. 2018;66:825–32.

    Article  CAS  PubMed  Google Scholar 

  30. Ellis ME, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis. 2001;32:50–62.

    Article  CAS  PubMed  Google Scholar 

  31. Yuan SM. Fungal endocarditis. Braz J Cardiovasc Surg. 2016;31:252–5.

    PubMed  PubMed Central  Google Scholar 

  32. Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation. 2015;132:1113–26.

    Article  PubMed  Google Scholar 

  33. Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, et al. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging. 2019;46:166–73.

    Article  CAS  PubMed  Google Scholar 

  34. De Camargo RA, Sommer Bitencourt M, Meneghetti JC, Soares J, Gonçalves LFT, Buchpiguel CA, et al. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of left-sided endocarditis: native vs prosthetic valves endocarditis. Clin Infect Dis. 2020;70:583–94.

    PubMed  Google Scholar 

  35. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075–128.

    Article  PubMed  Google Scholar 

  36. Hot A, Maunoury C, Poiree S, Lanternier F, Viard JP, Loulergue P, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect. 2011;17:409–17. https://doi.org/10.1111/j.1469-0691.2010.03301.x.

    Article  CAS  PubMed  Google Scholar 

  37. Salomäki SP, Saraste A, Jalava-Karvinen P, Pirilä L, Hohenthal U. Prosthetic valve Candida endocarditis: a case report with 18F-FDG-PET/CT as part of the diagnostic workup. Case Rep Cardiol. 2020;2020:1–4.

    Google Scholar 

  38. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25–31.

    Article  CAS  PubMed  Google Scholar 

  39. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60:892–9.

    Article  CAS  PubMed  Google Scholar 

  40. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52:750–70.

    Article  CAS  PubMed  Google Scholar 

  41. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1→3)-β-d-glucan assay for invasive fungal disease. Clin Infect Dis. 2009;49:1650–9.

    Article  CAS  PubMed  Google Scholar 

  42. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2015;62:e1–50.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Fioriti S, Brescini L, Pallotta F, Canovari B, Morroni G, Barchiesi F. Antifungal combinations against Candida species: from bench to bedside. J Fungi. 2022;8:1–18.

    Article  Google Scholar 

  44. O’Brien B, Chaturvedi S, Chaturvedi V. In vitro evaluation of antifungal drug combinations against multidrug-resistant Candida Auris isolates from New York outbreak. Antimicrob Agents Chemother. 2020;64:02195–219.

    Article  Google Scholar 

  45. Kujath P, Boos C, Lerch K, Kochendörfer P. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection. 1993;21:376–82.

    Article  CAS  PubMed  Google Scholar 

  46. Abele-Horn M, Kopp A, Sternberg U, Ohly A, Dauber A, Russwurm W, et al. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection. 1996;24:426–32.

    Article  CAS  PubMed  Google Scholar 

  47. Smego RA, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore). 2011;90:237–49.

    Article  CAS  PubMed  Google Scholar 

  48. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18:19–37.

    Article  CAS  PubMed  Google Scholar 

  49. Turnier E, Kay JH, Bernstein S, Mendez AM, Zubiate P. Surgical treatment of Candida endocarditis. Chest. 1975;67:262–8.

    Article  CAS  PubMed  Google Scholar 

  50. Steinbach WJ, Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230–47.

    Article  PubMed  Google Scholar 

  51. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–6.

    Article  PubMed  Google Scholar 

  52. Rivera NT, Bray N, Wang H, Zelnick K, Vicuña R, Osman A. Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review. Ther Adv Cardiovasc Dis. 2014;8:193–201.

    Article  PubMed  Google Scholar 

  53. Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses. 2011;54:10–4.

    Article  Google Scholar 

  54. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, et al. Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999. Am Heart J. 2004;147:582–6.

    Article  PubMed  Google Scholar 

  55. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device Infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590–1.

    Article  PubMed  Google Scholar 

  56. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the american heart association. Circulation. 2010;121:458–77.

    Article  PubMed  Google Scholar 

  57. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29:142–5. https://doi.org/10.1111/j.1540-8159.2006.00307.x.

    Article  PubMed  Google Scholar 

  58. Lekkerkerker JC, Van Nieuwkoop C, Trines SA, Van der Bom JG, Bernards A, Van de Velde ET, et al. Risk factors and time delay associated with cardiac device infections: leiden device registry. Heart. 2009;95:715–20.

    Article  CAS  PubMed  Google Scholar 

  59. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349–55.

    Article  PubMed  Google Scholar 

  60. Cohen TJ, Pons VG, Schwartz J, Griffin JC. Candida albicans pacemaker site infection. Pacing Clin Electrophysiol. 1991;14:146–8.

    Article  CAS  PubMed  Google Scholar 

  61. Wilson HA, Downes TR, Julian JS, White WL, Haponik EF. Candida endocarditis; a treatable form of pacemaker infection. Chest. 1993;103:283–4. https://doi.org/10.1378/chest.103.1.283.

    Article  PubMed  Google Scholar 

  62. Hebert J, Barr E, Magee C. Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient. BMJ Case Rep. 2021;14:2016–9.

    Article  Google Scholar 

  63. Joly V, Belmatoug N, Leperre A, Robert J, Jault F, Carbon C. Pacemaker Endocarditis Due to Candida albicans: Case Report and Review

  64. Roger PM, Boissy C, Gari-Toussaint M, Foucher R, Mondain V, Vandenbos F, et al. Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. J Infect. 2000;41:176–8.

    Article  CAS  PubMed  Google Scholar 

  65. Baman JR, Medhekar AN, Jain SK, Knight BP, Harrison LH, Smith B, et al. Management of systemic fungal infections in the presence of a cardiac implantable electronic device: a systematic review. Pacing Clin Electrophysiol. 2021;44:159–66. https://doi.org/10.1111/pace.14090.

    Article  PubMed  Google Scholar 

  66. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.

    Article  CAS  PubMed  Google Scholar 

  67. George MP, Esquer Garrigos Z, Vijayvargiya P, Anavekar NS, Luis SA, Wilson WR, et al. Discriminative ability and reliability of transesophageal echocardiography in characterizing cases of cardiac device lead vegetations versus noninfectious echodensities. Clin Infect Dis. 2021;72:1938–43.

    Article  CAS  PubMed  Google Scholar 

  68. Juneau D, Golfam M, Hazra S, Zuckier LS, Garas S, Redpath C, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device Infection. Circ Cardiovasc Imaging. 2017;10:1–11.

    Article  Google Scholar 

  69. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616–25.

    Article  PubMed  Google Scholar 

  70. Glöckner A. Recurrent candidaemia and pacemaker wire infection with Candida albicans. Mycoses. 2011;54:20–3.

    Article  PubMed  Google Scholar 

  71. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.

    Article  PubMed  Google Scholar 

  72. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167:669–75.

    Article  PubMed  Google Scholar 

  73. Yuzefpolskaya M, Schroeder SE, Houston BA, Robinson MR, Gosev I, Reyentovich A, et al. The society of thoracic surgeons intermacs 2022 annual report: focus on 2018 herat transplant allocation system. Ann Thorac Surg. 2022. https://doi.org/10.1016/j.biteb.2019.100310.

    Article  PubMed  PubMed Central  Google Scholar 

  74. de By TMMH, Schweiger M, Hussain H, Amodeo A, Martens T, Bogers AJJC, et al. The european registry for patients with mechanical circulatory support (EUROMACS): third paediatric (Paedi-EUROMACS) report. Eur J Cardio Thoracic Surg. 2022;62:355.

    Article  Google Scholar 

  75. Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis. 2006;6:426–37.

    Article  PubMed  Google Scholar 

  76. Simon D, Fischer S, Grossman A, Downer C, Hota B, Heroux A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108–15.

    Article  PubMed  Google Scholar 

  77. Kusne S, Staley L, Arabia F. Prevention and infection management in mechanical circulatory support device recipients. Clin Infect Dis. 2017;64:222–8.

    Article  PubMed  Google Scholar 

  78. Lahpor JR. State of the art: implantable ventricular assist devices. Curr Opin Organ Transpl. 2009;14:554–9.

    Article  CAS  Google Scholar 

  79. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.

    Article  CAS  PubMed  Google Scholar 

  80. Fuller R, Taimur S, Baneman E. Mechanical circulatory support infections in heart transplant candidates. Curr Infect Dis Rep. 2022;24:1–7. https://doi.org/10.1007/s11908-022-00772-7.

    Article  Google Scholar 

  81. Springer WE, Wasler A, Tadovancevic B, Myers T, Odegaard P, Macris MP, et al. Retrospective analysis of infection in patients underoging support with left ventricular assist systems. ASAIO J. 1996;42:M763-764.

    Article  CAS  PubMed  Google Scholar 

  82. Goldstein D, El-Amir N, Ashton R, Catanese K, Rose E, Levin H, et al. Fungal infections in left ventricular assist device recipients. ASAIO J. 1995;41:873–5.

    Article  CAS  PubMed  Google Scholar 

  83. Bagdasarian NG, Malani AN, Pagani FD, Malani PN. Fungemia associated with left ventricular assist device support: case reports. J Card Surg. 2009;24:763–5.

    Article  PubMed  Google Scholar 

  84. Aslam S, Xie R, Cowger J, Kirklin JK, Chu VH, Schueler S, et al. Bloodstream infections in mechanical circulatory support device recipients in the international society of heart and lung transplantation mechanically assisted circulation support registry: epidemiology, risk factors, and mortality. J Heart Lung Transpl. 2018;37:1013–20.

    Article  Google Scholar 

  85. Zinoviev R, Lippincott CK, Keller SC, Gilotra NA. In full flow: left ventricular assist device infections in the modern era. Open Forum Infectious Diseases. Oxford: Oxford University Press. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209633/. Accessed from 7 Dec 2022.

  86. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Hear Lung Transpl. 2011;30:375–84. https://doi.org/10.1016/j.healun.2011.01.717.

    Article  Google Scholar 

  87. Tattevin P, Flécher E, Auffret V, Leclercq C, Boulé S, Vincentelli A, et al. Risk factors and prognostic impact of left ventricular assist device–associated infections. Am Heart J. 2019;214:69–76. https://doi.org/10.1016/j.ahj.2019.04.021.

    Article  PubMed  Google Scholar 

  88. Aslam S, Hernandez M, Thornby J, Zeluff B, Darouiche RO. Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect Dis. 2010;50:664–71.

    Article  PubMed  Google Scholar 

  89. Broderick KL, Peters CJ, Mazurek JA, Wald J, Zhang RS, Atluri P, et al. Characteristics and outcomes of candidemia in patients with durable left ventricular assist device support. ASAIO J. 2022;68:1044–7.

    Article  CAS  PubMed  Google Scholar 

  90. Shoham S, Shaffer R, Sweet L, Cooke R, Donegan N, Boyce S. Candidemia in patients with ventricular assist devices. Clin Infect Dis. 2007;44:e9-12.

    Article  PubMed  Google Scholar 

  91. Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725–30.

    Article  CAS  PubMed  Google Scholar 

  92. Koval CE, Stosor V. Ventricular assist device-related infections and solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33:e13552.

    Article  Google Scholar 

  93. Taimur S, Sullivan T, Rana M, Patel G, Roldan J, Ashley K, et al. Successful heart transplantation in patients with total artificial heart infections. Transpl Infect Dis. 2018;20:1–5.

    Article  Google Scholar 

  94. Hidalgo LF, Shah KB, Cooke RH, Tang DG, Kasirajan V, Cooper HA, et al. Infections in patients with a total artificial heart are common but rarely fatal. ASAIO J. 2017;63:736–9.

    Article  PubMed  Google Scholar 

  95. de Vaugelade C, Mesguich C, Nubret K, Camou F, Greib C, Dournes G, et al. Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of 18 F-FDG PET/CT scan and leucocyte-labeled scintigraphy. J Nucl Cardiol. 2019;26:42–55.

    Article  PubMed  Google Scholar 

  96. Tam MC, Patel VN, Weinberg RL, Hulten EA, Aaronson KD, Pagani FD, et al. Diagnostic accuracy of FDG PET/CT in suspected LVAD Infections: a case series, systematic review, and meta-analysis. JACC Cardiovasc Imaging. 2018;13:1191–202.

    Article  Google Scholar 

  97. Litzler PY, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P, et al. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med. 2010;51:1044–8.

    Article  PubMed  Google Scholar 

  98. McCarthy PM, Schmitt SK, Vargo RL, Gordon S, Keys TF, Hobbs RE. Implantable LVAD infections: Implications for permanent use of the device. Ann Thorac Surg. 1996;61:359–65.

    Article  CAS  PubMed  Google Scholar 

  99. Chambers HE, Pelish P, Qiu F, Florescu DF. Perioperative prophylaxis for total artificial heart transplantation. Transpl Proc. 2017;49:2169–75. https://doi.org/10.1016/j.transproceed.2017.09.020.

    Article  CAS  Google Scholar 

  100. Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Prosthetic valve endocarditis after surgical aortic valve replacement. Circulation. 2017;136:329–31.

    Article  PubMed  Google Scholar 

  101. Murdoch DR, Corey RG, Hoen B, Miró M, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Funding

The authors have no relevant financial or non-financial interests to disclose.

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Risa Fuller & Samantha E. Jacobs

Authors
  1. Risa Fuller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samantha E. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed equally do this manuscript. RF drafted sections on epidemiology, clinical manifestations, management, and created Table 1. SJ drafted sections on diagnostics and critically reviewed the manuscript.

Corresponding author

Correspondence to Risa Fuller.

Ethics declarations

Conflict of interest

The authors have not disclosed any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Handling Editor: Ferry Hagen.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fuller, R., Jacobs, S.E. Candida Infectious Endocarditis and Implantable Cardiac Device Infections. Mycopathologia 188, 893–905 (2023). https://doi.org/10.1007/s11046-023-00745-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-023-00745-x

Keywords

Search

Navigation